Aberdeen Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$637M Buy
2,605,500
+67,013
+3% +$15.6M 1.03% 12
2025
Q4
$525M Buy
2,538,487
+47,996
+2% +$9.49M 0.81% 13
2025
Q3
$456M Sell
2,490,491
-238,558
-9% -$40.9M 0.72% 15
2025
Q2
$414M Buy
2,729,049
+20,450
+0.8% +$3.14M 0.7% 18
2025
Q1
$449M Buy
2,708,599
+760,488
+39% +$119M 0.88% 17
2024
Q4
$279M Sell
1,948,111
-115,036
-6% -$17.8M 0.52% 30
2024
Q3
$333M Sell
2,063,147
-109,978
-5% -$17.5M 0.61% 27
2024
Q2
$318M Buy
2,173,125
+258,245
+13% +$38.4M 0.61% 25
2024
Q1
$303M Sell
1,914,880
-99,863
-5% -$15.9M 0.59% 25
2023
Q4
$316M Buy
2,014,743
+1,027,441
+104% +$158M 0.68% 21
2023
Q3
$154M Sell
987,302
-136,082
-12% -$22.5M 0.39% 59
2023
Q2
$186M Buy
1,123,384
+34,004
+3% +$5.49M 0.43% 52
2023
Q1
$169M Sell
1,089,380
-25,612
-2% -$4.14M 0.42% 54
2022
Q4
$197M Buy
1,114,992
+66,370
+6% +$11.5M 0.54% 41
2022
Q3
$171M Sell
1,048,622
-66,510
-6% -$11.3M 0.51% 40
2022
Q2
$196M Buy
1,115,132
+33,467
+3% +$5.96M 0.62% 31
2022
Q1
$195M Sell
1,081,665
-330,956
-23% -$56.3M 0.5% 46
2021
Q4
$242M Sell
1,412,621
-191,778
-12% -$31.4M 0.53% 43
2021
Q3
$262M Sell
1,604,399
-108,948
-6% -$18.6M 0.59% 34
2021
Q2
$282M Sell
1,713,347
-975,885
-36% -$162M 0.62% 36
2021
Q1
$442M Buy
2,689,232
+86,089
+3% +$13.9M 1% 14
2020
Q4
$410M Sell
2,603,143
-43,534
-2% -$6.42M 1% 15
2020
Q3
$394M Sell
2,646,677
-162,104
-6% -$24M 1.05% 12
2020
Q2
$395M Sell
2,808,781
-124,466
-4% -$18.1M 1.07% 12
2020
Q1
$385M Sell
2,933,247
-662,184
-18% -$93.9M 1.22% 10
2019
Q4
$524M Sell
3,595,431
-743,176
-17% -$101M 1.27% 12
2019
Q3
$561M Sell
4,338,607
-811,974
-16% -$107M 1.4% 7
2019
Q2
$717M Sell
5,150,581
-229,387
-4% -$31.8M 1.59% 6
2019
Q1
$752M Sell
5,379,968
-454,513
-8% -$60.9M 1.63% 8
2018
Q4
$743M Sell
5,834,481
-199,869
-3% -$27.9M 1.76% 7
2018
Q3
$834M Sell
6,034,350
-366,015
-6% -$48.6M 1.55% 9
2018
Q2
$777M Buy
6,400,365
+197,153
+3% +$24.6M 1.49% 10
2018
Q1
$795M Buy
6,203,212
+69,113
+1% +$9.34M 1.58% 6
2017
Q4
$857M Sell
6,134,099
-9,748
-0.2% -$1.36M 1.64% 6
2017
Q3
$799M Buy
+6,143,847
New +$814M 1.46% 8

Other funds holding JNJ

Aberdeen Group's JNJ Position: Q1 2026 in Review

Aberdeen Group increased its Johnson & Johnson (JNJ) stake by 2.6% in Q1 2026, buying an estimated $15.6M and bringing the position to 2,605,500 shares worth $637M. The position accounts for 1.03% of the portfolio, ranked #12.

Aberdeen Group first reported a position in JNJ in Q3 2017 and has held it in 35 quarters since. The position peaked at $857M in Q4 2017. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Aberdeen Group held 2,605,500 shares of Johnson & Johnson worth $637M as of Q1 2026.
  • Aberdeen Group bought 67,013 Johnson & Johnson shares in Q1 2026, an estimated $15.6M.
  • Johnson & Johnson made up 1.03% of Aberdeen Group's portfolio in Q1 2026, its #12 holding.
  • Aberdeen Group first reported a position in Johnson & Johnson in Q3 2017 and has held it in 35 quarters since.
  • Aberdeen Group's Johnson & Johnson position peaked at $857M in Q4 2017.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.